PAParisa Azerang

Parisa Azerang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Parisa Azerang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Design and Synthesis of 2‐En‐4‐Ynedioate Compounds as Novel and Potential Antifungal Agents

    by Mohadese Mohammadi, Soroush Sardari, Parisa Azerang, Parviz Rashidi Ranjbar

    In this investigation, we focused on generating innovative antifungal agents inspired by terbinafine, a prominent allylamine that inhibits squalene epoxidase and is a crucial enzyme in the biosynthesis of fungal ergosterol. Utilizing computational methods such as molecular docking and molecular dynamics (MD) simulations, we designed and synthesized a collection of enyne derivatives featuring aromatic side chains. The choice of these compounds was influenced by their anticipated interactions with squalene epoxidase, informed by comprehensive in silico assessments. The synthesized derivatives were analyzed using 1 H‐NMR, 13 C‐NMR, and mass spectrometry techniques. Among the synthesized series, Compound 2b (1,6‐bis[(4‐methylphenyl)methyl] (2E)‐hex‐2‐en‐4‐ynedioate) exhibited potent antifungal activity, demonstrating a minimum inhibitory concentration (MIC) of 0.0391–0.7176 μ M/mL against Candida albicans , Saccharomyces cerevisiae , and Aspergillus niger . These findings highlight the promising strategy of applying these novel compounds, based on the structural design of terbinafine, as viable candidates for antifungal treatment. This approach demonstrates a significant advancement in the design of antifungal agents targeting squalene epoxidase and suggests promising avenues for further development.

  • Antibacterial efficacy of pyranopyrimidinone derivatives synthesized using a facile one-pot reaction

    by Nasrin Saberi Harooni, Fatemeh Dehghani Tafti, Nazanin Moghaddam, Hossein Naeimi, Parisa Azerang, Azar Tahghighi


  • Click chemistry beyond metal‐catalyzed cycloaddition as a remarkable tool for green chemical synthesis of antifungal medications

    by Azar Tahghighi, Parisa Azerang

    Click chemistry is widely used for the efficient synthesis of 1,4‐disubstituted‐1,2,3‐triazole, a well‐known scaffold with widespread biological activity in the pharmaceutical sciences. In recent years, this magic ring has attracted the attention of scientists for its potential in designing and synthesizing new antifungal agents. Despite scientific and medical advances, fungal infections still account for more than 1.5 million deaths globally per year, especially in people with compromised immune function. This increasing trend is definitely related to a raise in the incidence of fungal infections and prevalence of antifungal drug resistance. In this condition, an urgent need for new alternative antifungals is undeniable. By focusing on the main aspects of reaction conditions in click chemistry, this review was conducted to classify antifungal 1,4‐disubstituted‐1,2,3‐triazole hybrids based on their chemical structures and introduce the most effective triazole antifungal derivatives. It was notable that in all reactions studied, Cu(I) catalysts generated in situ by the reduction in Cu(II) salts or used copper(I) salts directly, as well as mixed solvents of t‐BuOH/H2O and DMF/H2O had most application in the synthesis of triazole ring. The most effective antifungal activity was also observed in fluconazole analogs containing 1,2,3‐triazole moiety and benzo‐fused five/six‐membered heterocyclic conjugates with a 1,2,3‐triazole ring, even with better activity than fluconazole. The findings of structure–activity relationship and molecular docking of antifungal derivatives synthesized with copper‐catalyzed azide–alkyne cycloaddition (CuAAC) could offer medicinal chemistry scientists valuable data on designing and synthesizing novel triazole antifungals with more potent biological activities in their future research.


  • Open Access

    Evaluation of Anti-Bacterial and Anti-Biofilm Activity of Native Probiotic Strains of Lactobacillus Extracts

    by Elmira Karimzadeh Barenji, Shokufeh Beglari, Azar Tahghighi, Parisa Azerang, Mahdi Rohani

    Background: Lactic acid bacteria produce various beneficial metabolites, including antimicrobial agents. Owing to the fast-rising antibiotic resistance among pathogenic microbes, scientists are exploring antimicrobials beyond antibiotics. In this study, we examined four Lactobacillus strains, namely L. plantarum 42, L. brevis 205, L. rhamnosus 239, and L. delbrueckii 263, isolated from ...


  • Synthesis and biological activity profile of novel triazole/quinoline hybrids

    by Hoda Jamshidi, Mohammad Reza Naimi‐Jamal, Maliheh Safavi, Kimia RayatSanati, Parisa Azerang, Azar Tahghighi

    Based on the significant and diverse pharmacophore features of triazole ring and considering the potent antimicrobial properties of quinoline scaffold, a novel series of 1,2,3‐triazole‐based polyaromatic compounds containing chloroquinoline moiety were synthesized through a well‐established synthetic methodology, named click chemistry. The structure of the synthetic compounds was characterized by various spectroscopic methods. The final products of triazole/quinoline hybrids and ((prop‐2‐yn‐1‐yloxy)methyl)benzene intermediates were screened for their antibacterial (Staphylococcus aureus, Escherichia coli, Shigella flexneri, and Salmonella enterica), antifungal (Candida albicans, Saccharomyces cerevisiae, and Aspergillus fumigatus), and cytotoxic activities. The best antifungal compounds exhibited minimum inhibitory concentration (MIC), in the range of 0.35–0.63 µM, against S. cerevisiae without any cytotoxic effect. These compounds can be selected as the potential candidates for treating invasive fungal infections caused by S. cerevisiae, after further investigation. Preliminary in silico ADME studies also predicted the favorable pharmacokinetic attributes of most compounds.


  • Design and Synthesis of New Antifungals Based on N-Un-substituted Azoles as 14α Demethylase Inhibitor

    by Asghar Davood, Aneseh Rahimi, Maryam Iman, Parisa Azerang, Soroush Sardari, Arash Mahboubi

    Objective(s): Azole antifungal agents, which are widely used as antifungal antibiotics, inhibit cytochrome P450 sterol 14α-demethylase (CYP51). Nearly all azole antifungal agents are N-substituted azoles. In addition, an azolylphenalkyl pharmacophore is uniquely shared by all azole antifungals. Due to importance of nitrogen atom of azoles (N-3 of imidazole and N-4 of triazole) in coordination with heme in the binding site of the enzyme, here a group of N- un-substituted azoles in which both of nitrogen is un-substituted was reported. Materials and Methods: Designed compounds were synthesized by reaction of imidazole-4-carboxaldehyde with appropriate arylamines and subsequently reduced to desired amine derivatives. Antifungal activity against Candida albicans and Saccharomyces cervisiae were done using a broth micro-dilution assay. Docking studies were done using AutoDock. Results: Antimicrobial evaluation revealed that some of these compounds exhibited moderate antimicrobial activities against tested pathogenic fungi, wherein compound 3, 7 and 8 were potent. Docking studies propose that all of the prepared azoles interacted with 14α-DM, wherein azole-heme coordination play main role in drug-receptor interaction. Conclusion: Our results offer some useful references in order to molecular design performance or modification of this series of compounds as a lead compound to discover new and potent antimicrobial agents.


  • Open Access

    Synthesis and biological evaluation of propargyl acetate derivatives as anti-mycobacterial agents

    by Parisa Azerang, Ali Hossein Rezayan, Soroush Sardari, Farzad Kobarfard, Mitra Bayat, Kimia Tabib

    Background: The emergence of multidrug-resistant strains of Mycobacterium tuberculosis (Mtb) has intensified efforts to discover novel drugs for tuberculosis (TB) treatment. Targeting the persistent state of Mtb, a condition in which Mtb is resistant to conventional drug therapies, is of particular interest. Methods: This study is focused on propargyl acetate derivatives. Eight molecules were designed based on propargyl alcohols and different acid anhydrides. Results: All the synthesized compounds and commercially available ones were evaluated for anti-tuberculosis activity. Conclusions: Inhibitors against Mtb have been identified and characterized for further development into potential novel anti-tubercular drugs.